Ajanta Pharma Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 42,087.1 million compared to INR 37,426.4 million a year ago. Revenue was INR 42,933.1 million compared to INR 38,412.8 million a year ago.

Net income was INR 8,161.7 million compared to INR 5,879.8 million a year ago. Basic earnings per share from continuing operations was INR 64.82 compared to INR 45.89 a year ago. Diluted earnings per share from continuing operations was INR 64.77 compared to INR 45.89 a year ago.